| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040501818 |
| P356 | DOI | 10.1007/S00441-014-1990-X |
| P932 | PMC publication ID | 4233112 |
| P698 | PubMed publication ID | 25209703 |
| P5875 | ResearchGate publication ID | 265557900 |
| P50 | author | Giuseppe Ippolito | Q28468788 |
| Mauro Piacentini | Q30111905 | ||
| Laura Falasca | Q56334017 | ||
| Manuela D'Eletto | Q56334441 | ||
| Carlo Rodolfo | Q56863263 | ||
| P2093 | author name string | Franca Del Nonno | |
| Maria Grazia Farrace | |||
| P2860 | cites work | Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway | Q24301518 |
| Transglutaminase 2: an enigmatic enzyme with diverse functions | Q28205648 | ||
| The function of tissue transglutaminase in celiac disease | Q28259501 | ||
| Role of transglutaminase 2 in celiac disease pathogenesis | Q28262529 | ||
| The role of transglutaminase-2 and its substrates in human diseases | Q28287957 | ||
| Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha | Q28289207 | ||
| The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis | Q60687719 | ||
| Inhibition of the formation of myotubes in vitro by inhibitors of transglutaminase | Q72697407 | ||
| Distinct nuclear localization and activity of tissue transglutaminase | Q74516745 | ||
| Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent | Q80133681 | ||
| Transglutaminase type II is involved in the pathogenesis of endotoxic shock | Q80633659 | ||
| Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment | Q81767265 | ||
| TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy | Q83821836 | ||
| Hyaluronic acid induces transglutaminase II to enhance cell motility; role of Rac1 and FAK in the induction of transglutaminase II. | Q40097761 | ||
| Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells | Q40322525 | ||
| Phosphorylation of histones by tissue transglutaminase. | Q40331106 | ||
| Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress | Q40725013 | ||
| Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. | Q41074541 | ||
| Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins | Q42064407 | ||
| A role for transglutaminase in neurotransmitter release by rat brain synaptosomes | Q42503358 | ||
| Role of transglutaminase in [3H]5-HT release from synaptosomes and in the inhibitory effect of tetanus toxin | Q42524286 | ||
| Tissue transglutaminase is a multifunctional BH3-only protein | Q42638167 | ||
| A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis | Q42802185 | ||
| Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity | Q42802854 | ||
| Transglutaminase 2 is involved in autophagosome maturation | Q43231650 | ||
| Histone cross-linking by transglutaminase | Q44020953 | ||
| The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling. | Q45916700 | ||
| TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer. | Q54448758 | ||
| Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix. | Q54600809 | ||
| Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes | Q33893946 | ||
| Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases | Q33926887 | ||
| Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation | Q34308397 | ||
| Transglutaminases: crosslinking enzymes with pleiotropic functions | Q35058528 | ||
| Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells. | Q35147626 | ||
| Histone modifiers in cancer: friends or foes? | Q35216079 | ||
| Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer | Q35387117 | ||
| At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. | Q35672020 | ||
| Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells | Q35683575 | ||
| Transglutaminase 2: a molecular Swiss army knife | Q35693361 | ||
| Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation | Q35697155 | ||
| Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance | Q36019962 | ||
| Transglutaminase 2 in the balance of cell death and survival | Q36156015 | ||
| Specific fluorescent labeling of chicken myofibril Z-line proteins catalyzed by guinea pig liver transglutaminase | Q36200346 | ||
| The role of tissue transglutaminase in cell-matrix interactions | Q36251149 | ||
| Roles of transglutaminases in cardiac and vascular diseases | Q36664166 | ||
| Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules | Q36768195 | ||
| Tissue transglutaminase and the stress response | Q36772428 | ||
| Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1 | Q37124999 | ||
| Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications | Q37316687 | ||
| Bcl-2 family on guard at the ER. | Q37412841 | ||
| Covalent modifications of histones during mitosis and meiosis. | Q37621183 | ||
| Transglutaminase 2: a multi-functional protein in multiple subcellular compartments | Q37690629 | ||
| Regulation of autophagy in mammals and its interplay with apoptosis. | Q37694356 | ||
| Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer | Q37769807 | ||
| Monitoring of transglutaminase 2 under different oxidative stress conditions. | Q37909103 | ||
| TG2, a novel extracellular protein with multiple functions | Q37912042 | ||
| Structure and regulation of type 2 transglutaminase in relation to its physiological functions and pathological roles | Q37973367 | ||
| Transglutaminase 2 at the crossroads between cell death and survival. | Q37973371 | ||
| Nitric oxide regulates non-classical secretion of tissue transglutaminase | Q38865948 | ||
| Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease | Q39448529 | ||
| Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells. | Q39490601 | ||
| Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells | Q39637744 | ||
| Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress | Q39888950 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 793-805 | |
| P577 | publication date | 2014-09-11 | |
| P1433 | published in | Cell and Tissue Research | Q1524113 |
| P1476 | title | Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states | |
| P478 | volume | 358 |
| Q33442546 | Cre/lox Studies Identify Resident Macrophages as the Major Source of Circulating Coagulation Factor XIII-A. |
| Q48167266 | Dissecting the interaction between transglutaminase 2 and fibronectin |
| Q39273075 | Effect of Some Growth Factors on Tissue Transglutaminase Overexpression Induced by β-Amyloid in Olfactory Ensheathing Cells. |
| Q89621128 | Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis |
| Q64917749 | Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C. |
| Q47767397 | Mutations in TGM6 induce the unfolded protein response in SCA35. |
| Q49959253 | Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. |
| Q101411039 | Proteomics-informed identification of luminal targets for in situ diagnosis of inflammatory bowel disease |
| Q61806085 | Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction |
| Q47730518 | Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia |
| Q88645716 | TG2 regulates the heat-shock response by the post-translational modification of HSF1 |
| Q64249805 | The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression |
| Q58064967 | Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies |
| Q38682039 | Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury |
| Q38746075 | Transglutaminase type 2 affects cell migration through post-translational modification of platelet-derived growth factor-BB. |
| Q47367907 | Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection. |
| Q92219315 | Transglutaminase-2 Mediates the Biomechanical Properties of the Colorectal Cancer Tissue Microenvironment that Contribute to Disease Progression |
| Q38937553 | Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target |
| Q26750714 | Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.